Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

641 - 650 of 44979 results found

Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis

Date
Tuesday, March 19, 2024 - 4:00 AM
Description
CONCLUSION: To our knowledge, this is the first report on the seroprevalence and longevity of SARS-CoV-2 IgG to 1 year in adults with CF after the widespread availability of SARS-CoV-2 vaccinations. These data show that pwCF respond to the COVID